Extracellular matrix protein 1 (ECM1) is over-expressed in malignant epithelial tumors

Cancer Lett. 2003 Oct 8;200(1):57-67. doi: 10.1016/s0304-3835(03)00350-1.

Abstract

The extracellular matrix protein 1 (ECM1) is a secreted protein that has been implicated with cell proliferation, angiogenesis and differentiation. In the present study, we used immunohistochemical staining to examine the expression of ECM1 in a panel of human tumors and found that it was closely correlated with some types of tumors including: invasive breast ductal carcinoma (83%), esophageal squamous carcinoma (73%), gastric cancer (88%) and colorectal cancer (78%). Significantly, ECM1expression was correlated with the metastatic properties of the tumors. Primary breast cancers that had formed metastases were 76% positive while those that had not metastasized were only 33% positive. ECM1 expression was also correlated with PCNA a marker for proliferation, but not with CD34, a marker for endothelial cells. These results indicate that ECM1 tends to be preferentially expressed by metastatic epithelial tumors.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antigens, CD34 / metabolism
  • Biomarkers, Tumor
  • Breast Neoplasms / metabolism
  • Carcinoma / metabolism*
  • Cell Division
  • Extracellular Matrix Proteins / immunology
  • Extracellular Matrix Proteins / metabolism*
  • Humans
  • Immunohistochemistry
  • Neoplasm Metastasis
  • Neoplasms / metabolism*
  • Neovascularization, Pathologic
  • Proliferating Cell Nuclear Antigen / metabolism

Substances

  • Antigens, CD34
  • Biomarkers, Tumor
  • ECM1 protein, human
  • Extracellular Matrix Proteins
  • Proliferating Cell Nuclear Antigen